Evolution and development of potent monobactam sulfonate candidate IMBZ18g as a dual inhibitor against MDR Gram-negative bacteria producing ESBLs
Monobactam
Drug-resistant Gram-negative bacteria
Chemoproteomic
Dual mode of action
Synergistic effect
© 2023 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V.
留言 (0)